van Kempen Evi J, Post Max, Mannil Manoj, Kusters Benno, Ter Laan Mark, Meijer Frederick J A, Henssen Dylan J H A
Department of Medical Imaging, Radboud University Medical Center, Radboud University, 6500HB Nijmegen, The Netherlands.
Clinic of Radiology, University Hospital Münster, WWU University of Münster, 48149 Münster, Germany.
Cancers (Basel). 2021 May 26;13(11):2606. doi: 10.3390/cancers13112606.
Treatment planning and prognosis in glioma treatment are based on the classification into low- and high-grade oligodendroglioma or astrocytoma, which is mainly based on molecular characteristics (IDH1/2- and 1p/19q codeletion status). It would be of great value if this classification could be made reliably before surgery, without biopsy. Machine learning algorithms (MLAs) could play a role in achieving this by enabling glioma characterization on magnetic resonance imaging (MRI) data without invasive tissue sampling. The aim of this study is to provide a performance evaluation and meta-analysis of various MLAs for glioma characterization. Systematic literature search and meta-analysis were performed on the aggregated data, after which subgroup analyses for several target conditions were conducted. This study is registered with PROSPERO, CRD42020191033. We identified 724 studies; 60 and 17 studies were eligible to be included in the systematic review and meta-analysis, respectively. Meta-analysis showed excellent accuracy for all subgroups, with the classification of 1p/19q codeletion status scoring significantly poorer than other subgroups (AUC: 0.748, = 0.132). There was considerable heterogeneity among some of the included studies. Although promising results were found with regard to the ability of MLA-tools to be used for the non-invasive classification of gliomas, large-scale, prospective trials with external validation are warranted in the future.
胶质瘤治疗中的治疗规划和预后基于低级别和高级别少突胶质细胞瘤或星形细胞瘤的分类,这主要基于分子特征(异柠檬酸脱氢酶1/2及1p/19q共缺失状态)。如果能在手术前且无需活检就能可靠地进行这种分类,将具有极大价值。机器学习算法(MLA)可以通过在磁共振成像(MRI)数据上对胶质瘤进行特征描述而无需进行侵入性组织采样来实现这一点。本研究的目的是对用于胶质瘤特征描述的各种MLA进行性能评估和荟萃分析。对汇总数据进行了系统的文献检索和荟萃分析,之后针对几种目标情况进行了亚组分析。本研究已在国际前瞻性系统评价注册库(PROSPERO)注册,注册号为CRD42020191033。我们识别出724项研究;分别有60项和17项研究符合纳入系统评价和荟萃分析的条件。荟萃分析显示所有亚组的准确性都很高,1p/19q共缺失状态的分类得分明显低于其他亚组(曲线下面积:0.748,标准差 = 0.132)。纳入的一些研究之间存在相当大的异质性。尽管在MLA工具用于胶质瘤非侵入性分类的能力方面发现了有前景的结果,但未来仍需要进行大规模、有外部验证的前瞻性试验。